Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort. [electronic resource]
Producer: 20080612Description: 532-8 p. digitalISSN:- 1555-7162
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Arthritis, Rheumatoid -- drug therapy
- Cohort Studies
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Multicenter Studies as Topic
- Patient Selection
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Reproduction
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.